Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Correction to: npj Breast Cancer 10.1038/s41523-023-00571-w, published online 05 August 2023 In this article the author name Scott Hoffmann, was incorrectly written as Scott Hoffman. The original article has been corrected.

Related collections

Author and article information

Contributors

Simon T. Barry:

ORCID: http://orcid.org/0000-0002-8511-0588

Simon.T.Barry@astrazeneca.com

Journal

Journal ID (nlm-ta): NPJ Breast Cancer

Journal ID (iso-abbrev): NPJ Breast Cancer

Title: NPJ Breast Cancer

Publisher: Nature Publishing Group UK (London )

ISSN (Electronic): 2374-4677

Publication date (Electronic): 18 August 2023

Publication date PMC-release: 18 August 2023

Publication date Collection: 2023

Volume: 9

Electronic Location Identifier: 69

Affiliations

[1 ]GRID grid.417815.e, ISNI 0000 0004 5929 4381, Bioscience Early Oncology, AstraZeneca, ; Cambridge, UK

[2 ]GRID grid.417815.e, ISNI 0000 0004 5929 4381, Early Data Science, Oncology Data Science, AstraZeneca, ; Cambridge, UK

[3 ]GRID grid.459399.b, ISNI 0000 0004 1769 4897, Information Technology, AstraZeneca, ; Chennai, Tamil Nadu India

[4 ]GRID grid.417815.e, ISNI 0000 0004 5929 4381, Imaging Sciences, AstraZeneca, ; Cambridge, UK

[5 ]GRID grid.418152.b, ISNI 0000 0004 0543 9493, Bioscience Early Oncology, AstraZeneca, ; Boston, MA USA

[6 ]GRID grid.417815.e, ISNI 0000 0004 5929 4381, Translational Medicine, AstraZeneca, ; Cambridge, UK

Author information

Lorna Hopcroft http://orcid.org/0000-0003-3689-7609

Stuart C. Williamson http://orcid.org/0000-0002-5209-4796

Susana Ros http://orcid.org/0000-0002-5451-1880

Larissa S. Carnevalli http://orcid.org/0000-0001-7432-0195

Elza DeBruin http://orcid.org/0000-0002-8996-8354

Simon T. Barry http://orcid.org/0000-0002-8511-0588

Article

Publisher ID: 575

DOI: 10.1038/s41523-023-00575-6

PMC ID: 10439172

PubMed ID: 37596288

SO-VID: 9d129129-4884-4a02-bf74-287c5101be60

License:

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

History

Custom metadata

Keywords: breast cancer,preclinical research

Data availability:

Keywords: breast cancer, preclinical research

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.